Deep brain stimulation for movement disorders: Assessing disparities in access to care
Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease
Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…Assessing the swallow tail sign in clinical practice
Objective: To evaluate the swallow tail sign accuracy to distinguish between essential tremor (ET) and Parkinson’s disease (PD) in clinical practice. Background: The swallow tail…How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial
Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…A validation study of the Mini-BESTest in a Spanish population with Parkinson’s disease.
Objective: Because the Mini Balance Evaluation Systems Test (Mini-BESTest) is widely used, our aim was to validate the Spanish version in PD. Background: Parkinson's disease…The Effects of Motor Imagery Therapy in the rehabilitation of patients with Parkinson’s Disease: A Systematic Review
Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with Motor Imagery Therapy. Background: Parkinson's disease (PD) is one of the most…Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease
Objective: This exploratory trial aims to compare treatment outcomes of adding one daily dose of opicapone (OPC) 50 mg versus an additional dose of levodopa…Sub-cellular alterations in MPTP-induced in-vivo and in-vitro systems and Non-MPTP human Parkinsonian skin biopsies: Verifying the sequelae of differential toxicity
Objective: To evaluate the possible temporal hierarchy of sub-cellular organellar degeneration in experimental models of Parkinson’s disease (PD), using MPTP/MPP+ Background: Higher prevalence of PD in…Genetic study of early-onset Parkinson’s disease in the Malaysian population
Objective: This study aimed to investigate the genetic architecture of EOPD in a multi-ethnic Malaysian cohort. Background: About 5-10% of Parkinson’s disease (PD) cases are…Sleep quality in GBA, LRRK2 and idiopathic Parkinson disease
Objective: To describe sleep characteristics and quality in GBA, LRRK2 and non-genetic idiopathic Parkinson disease. Background: Sleep disturbances are one of the most common non-motor…
- « Previous Page
- 1
- …
- 161
- 162
- 163
- 164
- 165
- …
- 338
- Next Page »